These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9779046)

  • 1. [Cutaneous vasculitis after hepatitis B vaccination with recombinant vaccine in a renal transplant patient].
    Bui-Quang D; Thomas E; Riols M; Levillain P; Picaud D; Séchet A; Baron M; Vérove C
    Presse Med; 1998 Sep; 27(26):1321-3. PubMed ID: 9779046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large artery vasculitis following recombinant hepatitis B vaccination: 2 cases.
    Zaas A; Scheel P; Venbrux A; Hellmann DB
    J Rheumatol; 2001 May; 28(5):1116-20. PubMed ID: 11361200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suspected hepatitis B vaccination related vasculitis.
    Le Hello C; Cohen P; Bousser MG; Letellier P; Guillevin L
    J Rheumatol; 1999 Jan; 26(1):191-4. PubMed ID: 9918261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary and cutaneous vasculitis following hepatitis B vaccination.
    Allen MB; Cockwell P; Page RL
    Thorax; 1993 May; 48(5):580-1. PubMed ID: 8322254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome following hepatitis B vaccination.
    Khamaisi M; Shoenfeld Y; Orbach H
    Clin Exp Rheumatol; 2004; 22(6):767-70. PubMed ID: 15638054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of rheumatoid arthritis after recombinant hepatitis B vaccination.
    Pope JE; Stevens A; Howson W; Bell DA
    J Rheumatol; 1998 Sep; 25(9):1687-93. PubMed ID: 9733447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe pancytopenia triggered by recombinant hepatitis B vaccine.
    Viallard JF; Boiron JM; Parrens M; Moreau JF; Ranchin V; Reiffers J; Leng B; Pellegrin JL
    Br J Haematol; 2000 Jul; 110(1):230-3. PubMed ID: 10931005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccination against hepatitis B in patients with chronic renal failure--twenty years follow-up].
    Roznovský L; Tvrdík J; Kabieszová L; Petrousová L; Orságová I; Hozáková L; Lochman I; Kloudová A; Valkovský I; Letocha P; Schwarzová S; Hladík M; Zjevíková A
    Vnitr Lek; 2011 Oct; 57(10):808-14. PubMed ID: 22097688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Occlusion of the central retinal vein after vaccination against viral hepatitis B with recombinant vaccines. 4 cases].
    Granel B; Disdier P; Devin F; Swiader L; Riss JM; Coupier L; Harlé JR; Jouglard J; Weiller PJ
    Presse Med; 1997 Feb; 26(2):62-5. PubMed ID: 9082411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arthus reaction to recombinant hepatitis B virus vaccine.
    Froehlich H; Verma R
    Clin Infect Dis; 2001 Sep; 33(6):906-8. PubMed ID: 11512098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain - Barre' syndrome following recombinant hepatitis B vaccine and literature review.
    Sinsawaiwong S; Thampanitchawong P
    J Med Assoc Thai; 2000 Sep; 83(9):1124-6. PubMed ID: 11075984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients.
    Gilbert CL; Stek JE; Villa G; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
    Vaccine; 2014 Nov; 32(48):6521-6. PubMed ID: 25252192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute myelitis after immunization against hepatitis B with recombinant vaccine].
    Senejoux A; Roulot D; Belin C; Tsakiris L; Rautureau J; Coste T
    Gastroenterol Clin Biol; 1996; 20(4):401-2. PubMed ID: 8758508
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical safety and efficacy of first indigenous recombinant hepatitis B vaccine.
    Kumar A; Joshi N; Sreenivas DV; Palan S; Nagarjuna Kumar YR
    J Assoc Physicians India; 1998 Jul; 46(7):620-2. PubMed ID: 12152846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
    Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
    J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient hepatitis B antigenemia in hemodialysis patients following hepatitis B vaccination.
    Kear TM; Wright LS
    ANNA J; 1996 Jun; 23(3):331, 337. PubMed ID: 8716993
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cutaneous polyarteritis nodosa following hepatitis B vaccination].
    Bourgeais AM; Dore MX; Croue A; Leclech C; Verret JL
    Ann Dermatol Venereol; 2003 Feb; 130(2 Pt 1):205-7. PubMed ID: 12671586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure.
    Watkins SL; Alexander SR; Brewer ED; Hesley TM; West DJ; Chan IS; Mendelman P; Bailey SM; Burns JL; Hogg RJ;
    Am J Kidney Dis; 2002 Aug; 40(2):365-72. PubMed ID: 12148110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Humoral immunity level and factors associated with the response to the vaccine against the hepatitis B virus in health personnel of the Case-Essalud National Hospital, Arequipa September 1995-March 2002].
    Campos Nizama J
    Rev Gastroenterol Peru; 2005; 25(2):141-9. PubMed ID: 16021199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Safety and immunogenicity of an anti-hepatitis-B vaccine obtained using the recombinant DNA technique: results of a longitudinal study in hospital personnel].
    Ricciardi G; Graziano G
    Boll Ist Sieroter Milan; 1990 Jun; 69(2):385-90. PubMed ID: 2152297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.